EP4076464 - COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.09.2022 Database last updated on 03.08.2024 | |
Former | The international publication has been made Status updated on 25.06.2021 | Most recent event Tooltip | 16.05.2024 | Supplementary search report | published on 12.06.2024 [2024/24] | Applicant(s) | For all designated states Orionis Biosciences, Inc. 950 Winter Street Waltham, MA 02451 / US | [2022/43] | Inventor(s) | 01 /
KLEY, Nikolai c/o Orionis Biosciences, Inc. 950 Winter Street Waltham, MA 02451 / US | 02 /
SABATINI, Riccardo c/o Orionis Biosciences, Inc. 950 Winter Street Waltham, MA 02451 / US | 03 /
SUH, Edward c/o Orionis Biosciences, Inc. 950 Winter Street Waltham, MA 02451 / US | [2022/43] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2022/43] | Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | Application number, filing date | 20901886.0 | 16.12.2020 | [2022/43] | WO2020US65303 | Priority number, date | US201962949027P | 17.12.2019 Original published format: US 201962949027 P | [2022/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021126973 | Date: | 24.06.2021 | Language: | EN | [2021/25] | Type: | A1 Application with search report | No.: | EP4076464 | Date: | 26.10.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.06.2021 takes the place of the publication of the European patent application. | [2022/43] | Search report(s) | International search report - published on: | US | 24.06.2021 | (Supplementary) European search report - dispatched on: | EP | 15.05.2024 | Classification | IPC: | C07D211/88, C07D401/04, C07D401/12, C07D401/14, C07D471/04, C07D487/04, C07D491/048, C07D491/056, C07D495/04, A61K45/06, A61K31/506 | [2024/12] | CPC: |
C07D401/04 (EP,US);
A61P35/00 (EP);
A61P43/00 (US);
C07D211/40 (US);
C07D211/88 (EP);
C07D401/12 (EP);
C07D401/14 (EP,US);
C07D405/14 (US);
C07D417/04 (US);
C07D471/04 (EP,US);
C07D487/04 (EP,US);
C07D491/048 (EP,US);
|
Former IPC [2022/43] | A61K31/506, A61K45/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/43] | Title | German: | VERBINDUNGEN ZUR MODULATION VON PROTEINREKRUTIERUNG UND/ODER -ABBAU | [2022/43] | English: | COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION | [2022/43] | French: | COMPOSÉS MODULANT LE RECRUTEMENT ET/OU LA DÉGRADATION DE PROTÉINES | [2022/43] | Entry into regional phase | 22.06.2022 | National basic fee paid | 22.06.2022 | Search fee paid | 22.06.2022 | Designation fee(s) paid | 22.06.2022 | Examination fee paid | Examination procedure | 22.06.2022 | Examination requested [2022/43] | 24.01.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 29.12.2022 | Renewal fee patent year 03 | 28.12.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2010053732 (CELGENE CORP [US], et al); | [I]WO2015038649 (SYNTA PHARMACEUTICALS CORP [US]); | [I]WO2017059062 (US HEALTH [US], et al); | [I]WO2017184995 (BIOVENTURES LLC [US]); | [I]WO2018052945 (UNIV MICHIGAN REGENTS [US]); | [X]WO2018071606 (ARVINAS INC [US]); | [I]WO2018102725 (ARVINAS INC [US]); | [I]WO2019078522 (KOREA RES INST CHEMICAL TECH [KR], et al); | International search | [A]WO2017197051 (C4 THERAPEUTICS INC [US]); | [A]CN107739389 (UNIV EAST CHINA NORMAL); | [A]WO2018106870 (ICAHN SCHOOL MED MOUNT SINAI [US]); |